MoonLake Net Debt from 2010 to 2024

MLTX Stock

USD 54.17 0.15 0.28%

MoonLake Immunotherapeuti Net Debt yearly trend continues to be fairly stable with very little volatility. Net Debt is likely to outpace its year average in 2024. Net Debt is the total debt of MoonLake Immunotherapeutics minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2010-12-31

Previous Quarter

-447.4 M

Current Value

-425 M

Quarterly Volatility

152.6 M

Credit Downgrade

Yuan Drop

Covid

Check MoonLake Immunotherapeuti financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MoonLake Immunotherapeuti's main balance sheet or income statement drivers, such as Depreciation And Amortization of 12.5 K, Other Operating Expenses of 34.1 M or Total Operating Expenses of 34.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 6.28. MoonLake financial statements analysis is a perfect complement when working with MoonLake Immunotherapeuti Valuation or Volatility modules.

Check out the analysis of MoonLake Immunotherapeuti Correlation against competitors.

Latest MoonLake Immunotherapeuti's Net Debt Growth Pattern

Below is the plot of the Net Debt of MoonLake Immunotherapeutics over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. MoonLake Immunotherapeuti's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MoonLake Immunotherapeuti's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

MoonLake Net Debt Regression Statistics

	Arithmetic Mean	(61,245,110)
	Geometric Mean	3,912,363
	Coefficient Of Variation	(249.19)
	Mean Deviation	99,982,408
	Median	(1,277,861)
	Standard Deviation	152,618,822
	Sample Variance	23292.5T
	Range	454.3M
	R-Value	(0.61)
	Mean Square Error	15844.7T
	R-Squared	0.37
	Significance	0.02
	Slope	(20,711,794)
	Total Sum of Squares	326095.1T

MoonLake Net Debt History

	2024	-425 M
	2023	-447.4 M
	2022	-39.2 M
	2021	7 M

Other Fundumenentals of MoonLake Immunotherapeuti

Net Debt To E B I T D A

MoonLake Immunotherapeuti Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Tangible Assets	Accounts Payable	Net Receivables	Deferred Long Term Liab	Net Invested Capital	Short Long Term Debt	Capital Stock	Net Working Capital	Property Plant Equipment	Capital Surpluse	Current Deferred Revenue
Total Assets		1.0	-0.98	-0.75	0.33	0.97	-0.17	-0.51	-0.7	-0.63	0.98	-0.94	0.98	-0.94	-0.74	0.97	0.88	-0.94	0.93
Total Stockholder Equity	1.0		-0.97	-0.71	0.28	0.96	-0.2	-0.47	-0.66	-0.59	0.97	-0.93	0.96	-0.93	-0.7	0.96	0.86	-0.93	0.92
Net Debt	-0.98	-0.97		0.86	-0.49	-1.0	0.01	0.67	0.79	0.73	-1.0	0.93	-1.0	0.93	0.82	-1.0	-0.95	0.93	-0.96
Retained Earnings	-0.75	-0.71	0.86		-0.74	-0.88	-0.28	0.95	0.92	0.9	-0.86	0.78	-0.87	0.78	0.93	-0.88	-0.91	0.78	-0.81
Total Liab	0.33	0.28	-0.49	-0.74		0.51	0.85	-0.87	-0.45	-0.43	0.5	-0.46	0.5	-0.46	-0.46	0.5	0.49	-0.46	0.47
Total Current Assets	0.97	0.96	-1.0	-0.88	0.51		0.01	-0.71	-0.81	-0.75	1.0	-0.94	1.0	-0.94	-0.84	1.0	0.94	-0.94	0.94
Short Term Debt	-0.17	-0.2	0.01	-0.28	0.85	0.01		-0.52	0.05	0.05	0.0	0.0	0.0	0.0	0.04	0.0	-0.02	0.0	0.01
Common Stock	-0.51	-0.47	0.67	0.95	-0.87	-0.71	-0.52		0.82	0.82	-0.68	0.61	-0.68	0.61	0.83	-0.7	-0.75	0.61	-0.62
Net Tangible Assets	-0.7	-0.66	0.79	0.92	-0.45	-0.81	0.05	0.82		0.99	-0.78	0.65	-0.79	0.65	0.99	-0.81	-0.92	0.65	-0.76
Accounts Payable	-0.63	-0.59	0.73	0.9	-0.43	-0.75	0.05	0.82	0.99		-0.71	0.62	-0.72	0.62	0.99	-0.75	-0.85	0.62	-0.67
Net Receivables	0.98	0.97	-1.0	-0.86	0.5	1.0	0.0	-0.68	-0.78	-0.71		-0.95	1.0	-0.95	-0.81	1.0	0.93	-0.95	0.94
Deferred Long Term Liab	-0.94	-0.93	0.93	0.78	-0.46	-0.94	0.0	0.61	0.65	0.62	-0.95		-0.95	1.0	0.74	-0.94	-0.78	1.0	-0.8
Net Invested Capital	0.98	0.96	-1.0	-0.87	0.5	1.0	0.0	-0.68	-0.79	-0.72	1.0	-0.95		-0.95	-0.82	1.0	0.93	-0.95	0.94
Short Long Term Debt	-0.94	-0.93	0.93	0.78	-0.46	-0.94	0.0	0.61	0.65	0.62	-0.95	1.0	-0.95		0.74	-0.94	-0.78	1.0	-0.8
Capital Stock	-0.74	-0.7	0.82	0.93	-0.46	-0.84	0.04	0.83	0.99	0.99	-0.81	0.74	-0.82	0.74		-0.85	-0.9	0.74	-0.75
Net Working Capital	0.97	0.96	-1.0	-0.88	0.5	1.0	0.0	-0.7	-0.81	-0.75	1.0	-0.94	1.0	-0.94	-0.85		0.94	-0.94	0.94
Property Plant Equipment	0.88	0.86	-0.95	-0.91	0.49	0.94	-0.02	-0.75	-0.92	-0.85	0.93	-0.78	0.93	-0.78	-0.9	0.94		-0.78	0.96
Capital Surpluse	-0.94	-0.93	0.93	0.78	-0.46	-0.94	0.0	0.61	0.65	0.62	-0.95	1.0	-0.95	1.0	0.74	-0.94	-0.78		-0.8
Current Deferred Revenue	0.93	0.92	-0.96	-0.81	0.47	0.94	0.01	-0.62	-0.76	-0.67	0.94	-0.8	0.94	-0.8	-0.75	0.94	0.96	-0.8

Click cells to compare fundamentals

About MoonLake Immunotherapeuti Financial Statements

MoonLake Immunotherapeuti investors use historical fundamental indicators, such as MoonLake Immunotherapeuti's Net Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MoonLake Immunotherapeuti. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Net Debt	-447.4 M	-425 M
Net Debt To EBITDA	8.27	6.27

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for MoonLake Stock Analysis

When running MoonLake Immunotherapeuti's price analysis, check to measure MoonLake Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MoonLake Immunotherapeuti is operating at the current time. Most of MoonLake Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of MoonLake Immunotherapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MoonLake Immunotherapeuti's price. Additionally, you may evaluate how the addition of MoonLake Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

MoonLake Net Debt from 2010 to 2024

Latest MoonLake Immunotherapeuti's Net Debt Growth Pattern

MoonLake Net Debt Regression Statistics

MoonLake Net Debt History

Other Fundumenentals of MoonLake Immunotherapeuti

MoonLake Immunotherapeuti Net Debt component correlations

About MoonLake Immunotherapeuti Financial Statements

Also Currently Popular

Additional Tools for MoonLake Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY